文|氨基观察提到基因疗法,蓝鸟生物是绕不开的一个存在。1992年,两位麻省理工学院的研究人员创立了蓝鸟生物的前身Genetix Pharmaceuticals。经过近20年的坚持,蓝鸟生物在基因疗法的努力方显成效。2010年,《nature》发布了一项临床试验结果,在蓝鸟生物Lentiglobin基因疗法的临床试验中,一位患有重型β地中海贫血的患者成功摆脱输血治疗。要知道,此前对于地中海贫血患者...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.